WO2002064761A3 - Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein - Google Patents

Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein Download PDF

Info

Publication number
WO2002064761A3
WO2002064761A3 PCT/EP2002/001260 EP0201260W WO02064761A3 WO 2002064761 A3 WO2002064761 A3 WO 2002064761A3 EP 0201260 W EP0201260 W EP 0201260W WO 02064761 A3 WO02064761 A3 WO 02064761A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
fatty acid
long chain
polyunsaturated fatty
chain polyunsaturated
protein
Prior art date
Application number
PCT/EP2002/001260
Other languages
French (fr)
Other versions
WO2002064761A2 (en )
Inventor
Zhimin Zhu
Original Assignee
Bayer Ag
Zhimin Zhu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Abstract

Reagents that regulate human long chain polyunsaturated fatty acid elongation enzyme-like protein and reagents which bind to human long chain polyunsaturated fatty acid elongation enzyme-like gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, diabetes, CNS disorder, metabolic disease, asthma or COPD.
PCT/EP2002/001260 2001-02-09 2002-02-07 Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein WO2002064761A3 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US26741501 true 2001-02-09 2001-02-09
US60/267,415 2001-02-09
US33144901 true 2001-11-16 2001-11-16
US60/331,449 2001-11-16
US33494801 true 2001-12-04 2001-12-04
US60/334,948 2001-12-04

Publications (2)

Publication Number Publication Date
WO2002064761A2 true WO2002064761A2 (en) 2002-08-22
WO2002064761A3 true true WO2002064761A3 (en) 2003-05-01

Family

ID=27401965

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/001260 WO2002064761A3 (en) 2001-02-09 2002-02-07 Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein

Country Status (1)

Country Link
WO (1) WO2002064761A3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007013479A3 (en) * 2005-07-27 2007-06-28 Oncotherapy Science Inc Genes and polypeptides relating to prostate cancers
WO2010070877A1 (en) * 2008-12-16 2010-06-24 Oncotherapy Science, Inc. Elovl7 epitope peptides and vaccines containing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012720A2 (en) * 1998-09-02 2000-03-09 Abbott Laboratories Elongase genes and uses thereof
WO2000070945A2 (en) * 1999-05-20 2000-11-30 Karolinska Innovations Ab Fatty acid elongation genes and uses thereof
WO2001004636A1 (en) * 1999-07-12 2001-01-18 Ohio University Mammalian cells expressing desaturases and elongases
WO2002044320A2 (en) * 2000-11-29 2002-06-06 Xenon Genetics Inc. Human elongase genes and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012720A2 (en) * 1998-09-02 2000-03-09 Abbott Laboratories Elongase genes and uses thereof
WO2000070945A2 (en) * 1999-05-20 2000-11-30 Karolinska Innovations Ab Fatty acid elongation genes and uses thereof
WO2001004636A1 (en) * 1999-07-12 2001-01-18 Ohio University Mammalian cells expressing desaturases and elongases
WO2002044320A2 (en) * 2000-11-29 2002-06-06 Xenon Genetics Inc. Human elongase genes and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 27 January 2000 (2000-01-27), XP002228622, retrieved from EBI Database accession no. AL137506 *
LEONARD AMANDA E ET AL: "Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids", BIOCHEMICAL JOURNAL, PORTLAND PRESS, LONDON, GB, vol. 350, no. 3, 2000, pages 765 - 770, XP002208697, ISSN: 0264-6021 *
OH ET AL: "ELO2 and ELO3, homologs of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 28, 11 July 1997 (1997-07-11), pages 17376 - 17384, XP002119019, ISSN: 0021-9258 *

Also Published As

Publication number Publication date Type
WO2002064761A2 (en) 2002-08-22 application

Similar Documents

Publication Publication Date Title
Tucci et al. Gastroesophageal reflux and bronchial asthma: prevalence and effect of cisapride therapy.
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
Mocchegiani et al. Zinc, infections and immunosenescence
WO2004024917A3 (en) Single-molecule in vitro evolution
Torrissen Genetic variation of trypsin-like isozymes correlated to fish size of Atlantic salmon (Salmo salar)
CN1231335A (en) Method for producing glossy ganoderma vinegar
WO2007021886A3 (en) Truncated memapsin 2 for use for treating alzheimer's disease
WO2003048204A1 (en) Alzheimer’s disease-associated gene and protein and use thereof
Simonato A pathogenetic hypothesis of temporal lobe epilepsy
Dugina et al. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis.
Park Nursing students' stress and anger experience in the clinical setting
WO2003055992A3 (en) A method for the establishment of a pluripotent human blastocyst-derived stem cell line
WO2004072294A3 (en) Methods and means for nucleic acid sequencing
CN101032515A (en) Healthy product for improving immunity
WO2001098491A3 (en) Osteolevin gene polymorphisms
Gemignani et al. Slow wave and rem sleep mechanisms are differently altered in hereditary pick disease associated with the TAU G389R mutation.
van der Kamp Dietary fibres and whole grain products for improving health and reducing disease risks
KR101813727B1 (en) Growth hormone polypeptides and methods of making and using same
CN201938548U (en) Combined type pearl jewelry
Pradat-Diehl et al. Long term outcome of a severe non fluent aphasia. The effect of prolonged rehabilitation
Ashton Reinventing drug development
CN103621838B (en) Duck increase primiparous premix and methods of using the duck egg weight
WO2003025149A8 (en) Cell populations which co-express cd49c and cd90
RU2006114832A (en) The process of differentiation of stem cells in the induction of myocardial
WO2005077042A3 (en) Albumin fusion proteins

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
WWW Wipo information: withdrawn in national office

Country of ref document: JP

NENP Non-entry into the national phase in:

Ref country code: JP